Sucralfate
Treatment for Gastritis And Duodenitis
Typical Dosage: 1g four times daily (before meals and at bedtime)
Effectiveness
68%
Safety Score
83%
Clinical Trials
400
Participants
40K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
83
DangerousModerateSafe
Treatment Details
Dosage Range
1g four times daily (before meals and at bedtime)
Time to Effect
Days for symptom relief, 4-8 weeks for healing
Treatment Duration
4-8 weeks
Evidence Quality
MODERATENumber Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$600
Monitoring:$50
Side Effect Mgmt:$10
Total Annual:$660
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$25,000/QALY
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$943
Cost per Remission
$1,100
Comparison vs Omeprazole (PPI)
Cost Difference
+$390/year
More expensive
QALY Difference
-0.10 QALYs
Worse outcomes
Dominance
No dominance
Prescription Access Economics
Annual Societal Loss per Patient
$495
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$125/year
Time Cost
$50/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$600/year
Potential OTC Price
$200/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOWMissed Diagnosis Risk
LOWSucralfate Outcomes
for Gastritis And Duodenitis
Efficacy Outcomes
Overall Effectiveness
+68%
Response Rate
+70%
Remission Rate
+60%
Common Side Effects
Constipation
+6%
Dry mouth
+3%
Nausea
+1%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov